Related Experiment Video
Updated: Jun 27, 2026

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins
Published on: April 17, 2020
Reprogramming Rotavirus: Reverse Genetics-Driven Design of Viral Vector Platforms.
Ke Li1, Xiao Wei1,2, Xuanze Ouyang1
1NHC Key Laboratory of Medical Virology and Viral Disease, National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Rotaviruses show promise as oral vaccine vectors due to their safety and ability to induce immunity. Advances in reverse genetics enable the development of new multivalent vaccines using rotaviruses (RV).
Area of Science:
- Virology
- Vaccinology
- Molecular Biology
Background:
- Rotaviruses are a primary cause of severe diarrhea and mortality in young children globally.
- Oral rotavirus vaccines have proven safe and effective, reducing disease burden and mortality.
- Rotaviruses possess inherent properties making them suitable as oral mucosal vaccine vectors.
Purpose of the Study:
- To review the historical development and current applications of rotavirus reverse genetics.
- To summarize progress in using rotaviruses as a vaccine vector platform for foreign antigens.
- To critically evaluate challenges and propose a design framework for improved rotavirus-based vectors.
Main Methods:
- Review of literature on rotavirus reverse genetics and vaccine vector development.
- Analysis of strategies for foreign gene insertion into the rotavirus genome.
- Evaluation of immunological outcomes in animal models using rotavirus vectors.
Main Results:
- Breakthroughs in reverse genetics, including plasmid-based systems, facilitate foreign antigen insertion.
- Rotavirus vectors have demonstrated potential for delivering foreign antigens and eliciting immune responses.
- Challenges include optimizing virus rescue efficiency, ensuring genetic insert stability, and addressing animal model limitations.
Conclusions:
- Rotaviruses represent a promising platform for developing novel oral mucosal vaccines.
- Further research is needed to overcome current challenges in rotavirus vector development for enhanced stability and immunogenicity.
- Rational design of rotavirus-based vectors is crucial for future vaccine applications.
